Thursday, 15 December 2016

Comparing the Use of Dopamine and Norepinephrine in Shock Treatment



Cardiovascular shock refers to a critical condition that occurs when a patient’s heart suddenly fails to pump blood as required by the body. This rare but fatal condition is mostly caused by heart attack and is linked to high death rate. The fluid administration that forms the firstline of therapeutic strategy does not offer enough stability for the condition of the patient, and the adrenergic agents are regularly needed to correct hypertension. Among the most frequently used agents are dopamine and norepinephrine. Both dopamine and norepinephrine affect the alpha-adrenergic and beta-adrenergic receptors, though to varying degrees. The effects of alpha-adrenergic receptors lead to increased vascular tone. However, it could decrease the cardiac output as well as the regional flow of blood, particularly in cutaneous, renal, and splanchnic beds.

Dopamine and Norepinephrine in Shock Treatment

On the other hand, beta-adrenergic effects assist in the maintenance of blood flow through inotropic and chronotropic effects as well asincreasing splanchnic perfusion. This stimulation from the betaadrenergiceffects can bring out the unwanted consequences, including an increase in the cellular metabolism and immunosuppressive effects

No comments:

Post a Comment